SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21220626
Source:
http://linkedlifedata.com/resource/pubmed/id/21220626
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008269
,
umls-concept:C0020336
,
umls-concept:C0035331
,
umls-concept:C0035648
,
umls-concept:C0087111
,
umls-concept:C0220908
,
umls-concept:C0332281
,
umls-concept:C0449258
,
umls-concept:C0600688
,
umls-concept:C1880019
pubmed:issue
1
pubmed:dateCreated
2011-1-11
pubmed:abstractText
To report the detailed clinical findings of patients with retinal toxicity that developed secondary to the use of hydroxychloroquine sulfate (n = 13), chloroquine phosphate (n = 2), or a combination of the agents (n = 1).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7706534
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Chloroquine
,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxychloroquine
,
http://linkedlifedata.com/resource/pubmed/chemical/chloroquine diphosphate
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1538-3601
pubmed:author
pubmed-author:FrancisPeter JPJ
,
pubmed-author:MichaelidesMichelM
,
pubmed-author:StoverNiamh BNB
,
pubmed-author:WeleberRichard GRG
pubmed:issnType
Electronic
pubmed:volume
129
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
30-9
pubmed:meshHeading
pubmed-meshheading:21220626-Adult
,
pubmed-meshheading:21220626-Aged
,
pubmed-meshheading:21220626-Aged, 80 and over
,
pubmed-meshheading:21220626-Antirheumatic Agents
,
pubmed-meshheading:21220626-Chloroquine
,
pubmed-meshheading:21220626-Disease Progression
,
pubmed-meshheading:21220626-Drug Therapy, Combination
,
pubmed-meshheading:21220626-Electroretinography
,
pubmed-meshheading:21220626-Female
,
pubmed-meshheading:21220626-Fluorescein Angiography
,
pubmed-meshheading:21220626-Humans
,
pubmed-meshheading:21220626-Hydroxychloroquine
,
pubmed-meshheading:21220626-Middle Aged
,
pubmed-meshheading:21220626-Retina
,
pubmed-meshheading:21220626-Retinal Diseases
,
pubmed-meshheading:21220626-Risk Factors
,
pubmed-meshheading:21220626-Tomography, Optical Coherence
,
pubmed-meshheading:21220626-Vision Disorders
,
pubmed-meshheading:21220626-Visual Field Tests
,
pubmed-meshheading:21220626-Visual Fields
pubmed:year
2011
pubmed:articleTitle
Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
pubmed:affiliation
Oregon Retinal Degeneration Center, Casey Eye Institute, Oregon Health & Science University, Portland, OR 97239-4197, USA.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't